Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DarioHealth Corp.DRIO · Entity 7024 | Director | October 03, 2018 | October 05, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DarioHealth Corp.
Report date October 03, 2018 · Filed October 05, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,811 |
Reported balance
After 2018-10-03 transaction · row 1
1 source rowRow 1 · 2018-10-03 · Grant · Acquired 6,288 · Balance 27,811 F1: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2018 in the amount of $6,250. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2018 in the amount of $6,250.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2018 Filed Oct 5, 2018 20:22 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 6,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-052745 · tv504213_form4.xml · nonDerivative · entry 1 Zanco Ori · CIK 0001743382 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,811 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2018 in the amount of $6,250. Read SEC document |
| July 09, 2018 Filed Jul 10, 2018 20:06 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 4,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-037838 · tv498256_form4.xml · nonDerivative · entry 1 Zanco Ori · CIK 0001743382 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,523 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2018 in the amount of $6,250. Read SEC document |
| June 06, 2018 Filed Jun 11, 2018 20:18 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 17,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-033746 · tv496318_form4.xml · nonDerivative · entry 1 Zanco Ori · CIK 0001743382 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,231 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.